Leadership Overview
Boston Scientific has 10 executives leading key functions including technology, information systems, finance, strategy, medical affairs, and regional operations.
Driven by innovation in medical technology, Boston Scientific is dedicated to transforming lives through the development and marketing of minimally invasive medical devices across a wide spectrum of interventional specialties, aiming to improve patient outcomes and healthcare efficiency globally.
Driven by innovation in medical technology, Boston Scientific is dedicated to transforming lives through the development and marketing of minimally invasive medical devices across a wide spectrum of interventional specialties, aiming to improve patient outcomes and healthcare efficiency globally.
Leadership Roles at Boston Scientific
Bernardo Del - Director, Finance (Country & Chief Financial Officer (Mexico)
Bernardo Del, the Director, Finance (Country & Chief Financial Officer (Mexico) at Boston Scientific, directs the financial operations and strategic fiscal planning for the Mexican market. This critical role involves managing all financial aspects, including budgeting, forecasting, financial reporting, and compliance within the region. Del ensures that financial strategies support Boston Scientific's growth objectives in Mexico, overseeing the financial health of operations and distribution networks. The Director, Finance (Country & Chief Financial Officer (Mexico) collaborates closely with regional leadership to optimize resource allocation and drive profitability. Bernardo Del's financial acumen is essential for navigating the complexities of the local market, ensuring adherence to regulatory requirements, and contributing to the company's overall financial performance and expansion across Latin America.
Daniel Brennan - Executive Vice President & Chief Financial Officer
Daniel Brennan, the Executive Vice President & Chief Financial Officer at Boston Scientific, oversees the company's global financial strategy, operations, and capital allocation. This senior leadership role encompasses managing all aspects of financial planning, accounting, treasury, investor relations, and mergers and acquisitions. Brennan drives financial discipline and performance across Boston Scientific's diverse business segments, including MedSurg and Cardiovascular, ensuring robust fiscal health and sustainable growth. The Executive Vice President & Chief Financial Officer plays a crucial part in capital markets activities, optimizing the company's financial structure, and communicating financial performance to stakeholders. Daniel Brennan's strategic financial leadership is instrumental in supporting Boston Scientific's innovation, global expansion, and commitment to delivering value to shareholders and patients worldwide.
Bas Burk - President
Bas Burk, the President at Boston Scientific, directs the overall strategic vision and operational execution across key business units. This leadership position involves driving growth, fostering innovation, and ensuring the company's continued success in the global medical device market. Burk oversees the integration of various functional areas, including research and development, manufacturing, sales, and marketing, to achieve corporate objectives. The President plays a vital role in shaping the company culture, promoting collaboration, and identifying new market opportunities. Bas Burk's leadership is focused on enhancing Boston Scientific's competitive position, expanding its global reach, and reinforcing its commitment to transforming lives through advanced medical technologies.
June Chang - President (Greater China)
June Chang, the President (Greater China) at Boston Scientific, leads the company's strategic operations and commercial expansion within the significant Greater China market. This executive role involves developing and executing market-specific strategies to drive revenue growth and increase market share for Boston Scientific's diverse portfolio of minimally invasive medical devices. Chang oversees all aspects of the regional business, including sales, marketing, distribution, and regulatory affairs, ensuring alignment with global corporate objectives. The President (Greater China) fosters strong relationships with healthcare providers, distributors, and government stakeholders to navigate the unique dynamics of the Chinese healthcare landscape. June Chang's leadership is crucial for capitalizing on the region's growth potential and reinforcing Boston Scientific's commitment to improving patient care in China.
Guangqiang Jiang - Chief Technology Officer
Guangqiang Jiang, the Chief Technology Officer at Boston Scientific, directs the overarching technology strategy and innovation pipeline. This leadership role involves identifying emerging technological trends and assessing their potential to advance the company's minimally invasive medical devices. Jiang oversees the research and development of next-generation technologies, ensuring Boston Scientific maintains its competitive edge in interventional cardiology, cardiac rhythm management, and other critical medical specialties. The Chief Technology Officer's focus extends to fostering a culture of innovation within the engineering and R&D teams, driving the creation of solutions that address unmet clinical needs. Guangqiang Jiang's strategic vision guides the integration of advanced materials, digital health capabilities, and novel engineering approaches into the product development lifecycle, ultimately supporting the company's mission to transform lives.
Charlene Stoessel - Chief Information Officer & Senior Vice President
Charlene Stoessel, the Chief Information Officer & Senior Vice President at Boston Scientific, architects the global information technology infrastructure and digital transformation initiatives. This executive role encompasses overseeing all aspects of IT operations, cybersecurity, data management, and enterprise systems that support Boston Scientific's worldwide manufacturing, distribution, and commercial activities. Stoessel drives the implementation of advanced digital solutions to enhance operational efficiency, streamline supply chain management, and improve data analytics capabilities across the MedSurg and Cardiovascular segments. The Chief Information Officer & Senior Vice President ensures that technology investments align with strategic business objectives, enabling seamless collaboration among global teams and supporting the company's expansion into new markets. Charlene Stoessel's leadership ensures robust and scalable IT systems that underpin Boston Scientific's commitment to innovation and global healthcare access.
Chan Ella - Vascular Strategy Lead Chief of Staff
Chan Ella, the Vascular Strategy Lead Chief of Staff at Boston Scientific, drives strategic initiatives and operational alignment within the vascular business unit. This executive position focuses on enhancing the strategic planning process, facilitating cross-functional collaboration, and ensuring the effective execution of key programs. Ella supports the leadership team in developing and implementing long-term strategies for the vascular intervention and peripheral interventions portfolios. The Vascular Strategy Lead Chief of Staff plays a pivotal role in market analysis, competitive intelligence, and identifying new growth opportunities. Chan Ella's responsibilities include streamlining communication channels, managing critical projects, and ensuring that strategic objectives translate into tangible business outcomes, thereby advancing Boston Scientific's leadership in vascular solutions.
Rafael Carbunaru - Chief Technology Officer, Neuromodulation
Rafael Carbunaru, the Chief Technology Officer, Neuromodulation at Boston Scientific, spearheads technological innovation and product development within the neuromodulation division. This specialized role involves directing the research, design, and engineering of advanced therapies and devices for conditions such as chronic pain, movement disorders, and epilepsy. Carbunaru leads a team of scientists and engineers focused on developing cutting-edge technologies that improve patient quality of life through minimally invasive interventions. The Chief Technology Officer, Neuromodulation ensures that technological advancements align with clinical needs and regulatory requirements, driving the pipeline of next-generation neuromodulation solutions. Rafael Carbunaru's expertise is critical in maintaining Boston Scientific's leadership in this complex and rapidly evolving field, fostering innovation that directly impacts patient care.
Ronald Morton - Chief Medical Officer
Ronald Morton, the Chief Medical Officer at Boston Scientific, provides critical clinical insights and medical expertise to guide product development and strategic initiatives. This executive role involves ensuring that all medical devices and technologies meet the highest standards of patient safety and clinical efficacy. Morton collaborates closely with R&D, marketing, and regulatory affairs teams to translate clinical needs into innovative solutions across Boston Scientific's broad portfolio. The Chief Medical Officer champions evidence-based medicine, oversees clinical trial strategies, and engages with the global medical community to gather feedback and identify unmet clinical needs. Ronald Morton's leadership ensures that Boston Scientific's innovations are clinically relevant and contribute significantly to improving patient outcomes worldwide.
Brad Sutton - Chief Medical Officer, Af Solutions (Ep & Watchman)
Brad Sutton, the Chief Medical Officer, Af Solutions (Ep & Watchman) at Boston Scientific, provides specialized clinical leadership for the company's electrophysiology and Watchman device portfolios. This critical role focuses on advancing the clinical understanding and application of technologies designed to treat atrial fibrillation and other cardiac conditions. Sutton guides clinical strategy, oversees pivotal clinical trials, and collaborates with physicians to ensure optimal patient outcomes and device performance. The Chief Medical Officer, Af Solutions (Ep & Watchman) acts as a key liaison between the medical community and the R&D teams, translating clinical insights into product improvements and new therapeutic approaches. Brad Sutton's expertise is essential for maintaining Boston Scientific's leadership in cardiac rhythm management and AF solutions.
Explore Leadership Teams in Manufacturing
Merit Medical Systems, Inc. is a prominent manufacturer and marketer specializing in proprietary disposable medical devices designed to support hospitals and healthcare providers around the world. Since its founding in the late twentieth century, the company has developed a reputation for innovation and quality in the medical device industry. Merit Medical is dedicated to understanding the needs of its clients and advancing healthcare through the development of cutting-edge products that improve patient outcomes and clinical efficiency.
Company Leadership
RR
Hologic is a global medical technology leader focused on improving womens health and wellbeing through early detection, diagnosis, and treatment solutions. The company develops and supplies advanced diagnostic products, imaging systems, and surgical tools that support clinical care across breast health, gynecological care and infectious disease testing. With a strong innovation culture and worldwide presence, Hologic partners with healthcare professionals to raise standards of care and help patients live healthier lives.
Company Leadership
Based in Buffalo, NY, Nissha Medical Technologies (NMT) is the medical devices business unit and wholly owned subsidiary of Nissha Co. Ltd.. The company offers services, including Design & Manufacturing, Healthcare Solutions and Custom Labeled Products.
Company Leadership
SD
JC
Confluent Applies Materials Science to MedTech Innovation. Confluent's engineered solutions to the most challenging design problems enable our OEM medical device customers to offer life-saving products. Our customers rely on Confluent for materials science and associated manufacturing expertise which is critical to the function and value of their most demanding, high growth products - proprietary expertise which spans processing of high purity Nitinol, ultra-high density knitting of biomedical textiles and precision laser treatment of specialty polymers. Confluent partners with leading OEMs to create a selective product portfolio which includes such complex applications as transcatheter heart valves, neurovascular implants, endovascular stent grafts and advanced smart catheters. With facilities in Fremont and Laguna Niguel, California; Warwick, Rhode Island; Windham, Maine; Austin, Texas; Chattanooga, Tennessee; and San Jose, Costa Rica, Confluent has earned the confidence of the leaders in the medical device community through a proven track record of innovative materials science, engineering and manufacturing.
Company Leadership
JG
EP
ME
Frequently Asked Questions Regarding Boston Scientific Top Executives and Leadership Team
Unlock more people and company data
